Please login to the form below

Not currently logged in
Email:
Password:

Artios Pharma

This page shows the latest Artios Pharma news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Merck KGaA has signed a strategic collaboration agreement with Artios Pharma to develop precision cancer medicines targeting DNA damage response pathways. ... Under the terms of the agreement, Merck KGaA will pay Artios $30m upfront, as well as near-term

Latest news

  • UK biotech Artios Pharma appoints new medical director UK biotech Artios Pharma appoints new medical director

    Joins from senior role at Lilly. UK-based Artios Pharma has unveiled Dr Ian Smith, former Lilly and AstraZeneca clinical development leader, as its new chief medical officer. ... The Artios pipeline offers one of the most exciting approaches to cancer

  • DNA damage specialists Artios Pharma raises $84m DNA damage specialists Artios Pharma raises $84m

    Team behind development of Lynparza focus on next-gen DDR inhibitors. Cambridge, UK-based Artios Pharma has raised $84 million (£65 million) in a series B financing. ... Artios’ existing shareholders Arix Bioscience, SV Health Investors, M Ventures,

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Artios Pharma appoints science strategy VP Artios Pharma appoints science strategy VP

    Francis Crick Institute lead Dr Simon Boulton joins management team. Cambridge, UK-based Artios Pharma has appointed Dr Simon Boulton as vice president of science strategy. ... He brings over 20 years of expertise in DNA repair and the treatment of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics